- Home
- MCRB vs OCFT Comparison
MCRB vs OCFT Comparison
Compare MCRB & OCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- OCFT
- Stock Information
- Founded
- MCRB 2010
- OCFT 2015
- Country
- MCRB United States
- OCFT China
- Employees
- MCRB N/A
- OCFT N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- OCFT Computer Software: Programming Data Processing
- Sector
- MCRB Health Care
- OCFT Technology
- Exchange
- MCRB Nasdaq
- OCFT Nasdaq
- Market Cap
- MCRB 141.9M
- OCFT 169.6M
- IPO Year
- MCRB 2015
- OCFT 2019
- Fundamental
- Price
- MCRB $0.72
- OCFT $6.81
- Analyst Decision
- MCRB Hold
- OCFT Strong Buy
- Analyst Count
- MCRB 5
- OCFT 1
- Target Price
- MCRB $4.00
- OCFT $7.00
- AVG Volume (30 Days)
- MCRB 840.7K
- OCFT 196.8K
- Earning Date
- MCRB 03-13-2025
- OCFT 03-18-2025
- Dividend Yield
- MCRB N/A
- OCFT N/A
- EPS Growth
- MCRB N/A
- OCFT N/A
- EPS
- MCRB 0.00
- OCFT N/A
- Revenue
- MCRB N/A
- OCFT $307,997,287.00
- Revenue This Year
- MCRB N/A
- OCFT N/A
- Revenue Next Year
- MCRB N/A
- OCFT $6.37
- P/E Ratio
- MCRB $824.00
- OCFT N/A
- Revenue Growth
- MCRB N/A
- OCFT N/A
- 52 Week Low
- MCRB $0.54
- OCFT $0.87
- 52 Week High
- MCRB $1.53
- OCFT $6.90
- Technical
- Relative Strength Index (RSI)
- MCRB 46.92
- OCFT 75.33
- Support Level
- MCRB $0.69
- OCFT $6.55
- Resistance Level
- MCRB $0.76
- OCFT $6.85
- Average True Range (ATR)
- MCRB 0.05
- OCFT 0.24
- MACD
- MCRB 0.00
- OCFT -0.09
- Stochastic Oscillator
- MCRB 53.55
- OCFT 89.19
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.